Common Stock, Value, Issued of NKGen Biotech, Inc. from 31 Mar 2021 to 31 Mar 2025

Taxonomy & unit
us-gaap: USD
Description
Aggregate par or stated value of issued nonredeemable common stock (or common stock redeemable solely at the option of the issuer). This item includes treasury stock repurchased by the entity. Note: elements for number of nonredeemable common shares, par value and other disclosure concepts are in another section within stockholders' equity.
Summary
NKGen Biotech, Inc. quarterly Common Stock, Value, Issued in USD history and change rate from 31 Mar 2021 to 31 Mar 2025.
  • NKGen Biotech, Inc. Common Stock, Value, Issued for the quarter ending 31 Mar 2025 was $5,000, a 150% increase year-over-year.
Source SEC data
View on sec.gov
Common Stock, Value, Issued, Quarterly (USD)
Common Stock, Value, Issued, YoY Quarterly Change (%)

NKGen Biotech, Inc. Quarterly Common Stock, Value, Issued (USD)

Period Value YoY Chg Change % Date Report Filed Fiscal Year Fiscal Period
Q1 2025 $5,000 +$3,000 +150% 31 Mar 2025 10-Q 20 Jan 2026 2025 Q1
Q4 2024 $4,000 +$2,000 +100% 31 Dec 2024 10-Q 20 Jan 2026 2025 Q1
Q3 2024 $4,000 +$2,000 +100% 30 Sep 2024 10-Q 04 Mar 2025 2024 Q3
Q2 2024 $3,000 30 Jun 2024 10-Q 12 Sep 2024 2024 Q2
Q1 2024 $2,000 31 Mar 2024 10-Q 20 May 2024 2024 Q1
Q4 2023 $2,000 +$1,000 +100% 31 Dec 2023 10-K 08 Oct 2025 2024 FY
Q3 2023 $2,000 30 Sep 2023 10-Q 14 Nov 2023 2023 Q3
Q4 2022 $1,000 +$571 +133% 31 Dec 2022 10-K 16 Apr 2024 2023 FY
Q2 2022 $429 $0 0% 30 Jun 2022 10-Q 15 Aug 2022 2022 Q2
Q1 2022 $429 -$2 -0.46% 31 Mar 2022 10-Q 16 May 2022 2022 Q1
Q4 2021 $429 31 Dec 2021 10-Q 15 Aug 2022 2022 Q2
Q3 2021 $429 30 Sep 2021 10-Q/A 31 Jan 2022 2021 Q3
Q2 2021 $429 30 Jun 2021 10-Q/A 31 Jan 2022 2021 Q3
Q1 2021 $431 31 Mar 2021 10-Q 02 Jul 2021 2021 Q1
* An asterisk sign (*) next to the value indicates that the value is likely invalid.